GlobalAlzheimer's: "Donanimab" may be a turning point in treating and slowing the...

Alzheimer’s: “Donanimab” may be a turning point in treating and slowing the disease – . .

image copyright GettyImages

A new drug called donanimab has been hailed as a turning point in the fight against Alzheimer’s disease, after results from a global trial confirmed that it slows cognitive decline.

Antibody medication helps in the early stages of the disease by getting rid of a protein that builds up in the brains of people with this type of dementia.

Although not a cure-all, charities say the findings, published in JAMA The Journal of the American Medical Association, mark a new era in which Alzheimer’s disease can be treated.

The UK’s Medicines Regulatory Authority has begun evaluating it for possible use in the National Health Service (NHS).

Daily Global Times
Daily Global Times provides the latest news from India and around the world. Read the latest headlines and news stories, from Politics, Entertainment, Tech and more.

Related Article

Editors Picks